By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Amersham Biosciences 

Bristol-Myers Squibb 

PanVera LLC 

Rigel 

Massachusetts Life Sciences Center 





Company News
Study Reveals More Than One-Third of Hip Implants Made by Johnson & Johnson (JNJ)'s DePuy Synthes Were the Wrong Size 4/29/2016 7:29:25 AM
Johnson & Johnson (JNJ) Announces Dividend Increase Of 6.7% 4/28/2016 10:12:25 AM
Five Johnson & Johnson (JNJ) Pinnacle Plaintiffs Fight for Full $360 Million Punitive-Damage Award 4/25/2016 7:19:28 AM
Johnson & Johnson (JNJ) To Participate In The 2016 Deutsche Bank (DB) 41st Annual Health Care Conference 4/21/2016 12:25:03 PM
H.I.G. BioHealth Partners Completes Successful Sale Of NeuWave Medical To Ethicon (JNJ), A Johnson & Johnson (JNJ) Company 4/19/2016 11:23:18 AM
Johnson & Johnson (JNJ) Reports 2016 First-Quarter Results 4/19/2016 7:32:02 AM
Johnson & Johnson (JNJ) Must Pay Up for Luring Away Rival's Employee 4/15/2016 7:29:39 AM
Johnson & Johnson (JNJ) Announces Launch Of New Global Public Health Strategy At Opening Of New Operations In Africa 4/6/2016 6:45:55 AM
Massachusetts' Tesaro (TSRO) Inks $450 Million Prostate Cancer Deal with Drug Giant Johnson & Johnson (JNJ) 4/6/2016 6:38:47 AM
FDA Approves Celltrion (068270.KQ)’s INFLECTRA, the First Cheaper Version of Johnson & Johnson (JNJ) Blockbuster Remicade 4/6/2016 6:19:31 AM
12345678910...
//-->